Literature DB >> 15893495

Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts.

Alison R Kerr1, Lea Ann S Kirkham, Aras Kadioglu, Peter W Andrew, Paul Garside, Hal Thompson, Tim J Mitchell.   

Abstract

Gram-positive sepsis is a major disease problem. However, the contribution of various immune cell types to pathogenesis remains unclear. By infecting scid and wild type BALB/c mice with Streptococcus pneumoniae we have found a situation in which natural killer (NK) cells can play a detrimental role in the response to infection. scid mice were found to be significantly more susceptible to local and systemic pneumococcal infection than controls; they had significantly higher bacterial loads, elevated inflammatory responses and more widespread lung pathology. Interestingly, depletion of NK cells in scid mice resulted in significantly lower bacteraemia and inflammatory cytokine production. Infection with pneumococci deficient in pneumolysin revealed the toxin was involved in cytokine production. Overall results indicate that elevated NK cell activity during pneumococcal pneumonia amplifies pulmonary and systemic inflammation, increases bacteraemia and results in poor outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893495     DOI: 10.1016/j.micinf.2005.02.011

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  30 in total

1.  IL-10-producing NK cells exacerbate sublethal Streptococcus pneumoniae infection in the lung.

Authors:  Sarah E Clark; Rebecca L Schmidt; Elizabeth R Aguilera; Laurel L Lenz
Journal:  Transl Res       Date:  2020-07-04       Impact factor: 7.012

Review 2.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

3.  Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock.

Authors:  Daniela S Herzig; Brandon R Driver; Geping Fang; Tracy E Toliver-Kinsky; Eric N Shute; Edward R Sherwood
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

4.  CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice.

Authors:  Sarah E Weber; Haijun Tian; Liise-anne Pirofski
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

5.  Analysis of murine genetic predisposition to pneumococcal infection reveals a critical role of alveolar macrophages in maintaining the sterility of the lower respiratory tract.

Authors:  Keer Sun; Yan Gan; Dennis W Metzger
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

6.  Effects of anti-inflammatory vagus nerve stimulation in endotoxemic rats on blood and spleen lymphocyte subsets.

Authors:  S Mihaylova; H Schweighöfer; H Hackstein; B Rosengarten
Journal:  Inflamm Res       Date:  2014-05-07       Impact factor: 4.575

7.  Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection.

Authors:  Charalambos Gogos; Antigone Kotsaki; Aimilia Pelekanou; George Giannikopoulos; Ilia Vaki; Panagiota Maravitsa; Stephanos Adamis; Zoi Alexiou; George Andrianopoulos; Anastasia Antonopoulou; Sofia Athanassia; Fotini Baziaka; Aikaterini Charalambous; Sofia Christodoulou; Ioanna Dimopoulou; Ioannis Floros; Efthymia Giannitsioti; Panagiotis Gkanas; Aikaterini Ioakeimidou; Kyriaki Kanellakopoulou; Niki Karabela; Vassiliki Karagianni; Ioannis Katsarolis; Georgia Kontopithari; Petros Kopterides; Ioannis Koutelidakis; Pantelis Koutoukas; Hariklia Kranidioti; Michalis Lignos; Konstantinos Louis; Korina Lymberopoulou; Efstratios Mainas; Androniki Marioli; Charalambos Massouras; Irini Mavrou; Margarita Mpalla; Martha Michalia; Heleni Mylona; Vassilios Mytas; Ilias Papanikolaou; Konstantinos Papanikolaou; Maria Patrani; Ioannis Perdios; Diamantis Plachouras; Aikaterini Pistiki; Konstantinos Protopapas; Kalliopi Rigaki; Vissaria Sakka; Monika Sartzi; Vassilios Skouras; Maria Souli; Aikaterini Spyridaki; Ioannis Strouvalis; Thomas Tsaganos; George Zografos; Konstantinos Mandragos; Phylis Klouva-Molyvdas; Nina Maggina; Helen Giamarellou; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  Crit Care       Date:  2010-05-26       Impact factor: 9.097

8.  Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.

Authors:  D M Ferreira; M Darrieux; D A Silva; L C C Leite; J M C Ferreira; P L Ho; E N Miyaji; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

Review 9.  Natural killer cells in infection and inflammation of the lung.

Authors:  Fiona J Culley
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

10.  Therapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis.

Authors:  Daniela S Herzig; Yin Guo; Geping Fang; Tracy E Toliver-Kinsky; Edward R Sherwood
Journal:  Crit Care       Date:  2012-09-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.